Work

Abstract 1683: Combining annamycin, a non-cardiotoxic potent topo II poison, with azacitidine, cytarabine, gemcitabine, ifosfamide, trabectedin, or vincristine to synergize anticancer effects and identify potential clinical applications

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1683

Authors: Rafal J. Zielinski, Krzysztof Grela, Stanislaw Skora, Izabela Fokt, Roberto Cardenaz-Zuniga, Natalia Baran, Waldemar Priebe

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409624979

Cites:

Cited by:

Related to: 10